These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

650 related items for PubMed ID: 15700491

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A combined analysis of double-blind trials of the efficacy and tolerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia.
    Kirby RS, Andersen M, Gratzke P, Dahlstrand C, Høye K.
    BJU Int; 2001 Feb; 87(3):192-200. PubMed ID: 11167641
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of extended-release doxazosin and doxazosin standard in patients with concomitant benign prostatic hyperplasia and sexual dysfunction.
    Kirby RS, O'Leary MP, Carson C.
    BJU Int; 2005 Jan; 95(1):103-9; discussion 109. PubMed ID: 15638905
    [Abstract] [Full Text] [Related]

  • 5. A double-blind placebo-controlled study evaluating the onset of action of doxazosin gastrointestinal therapeutic system in the treatment of benign prostatic hyperplasia.
    Roehrborn CG, Prajsner A, Kirby R, Andersen M, Quinn S, Mallen S.
    Eur Urol; 2005 Sep; 48(3):445-52; discussion 452. PubMed ID: 15996811
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of the doxazosin gastrointestinal therapeutic system for the treatment of benign prostate hyperplasia.
    Sun GH, Tsui KH, Wu TT, Chang CH, Cheng CL, Schou M.
    Kaohsiung J Med Sci; 2010 Oct; 26(10):532-9. PubMed ID: 20950778
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of tamsulosin hydrochloride compared to doxazosin in the treatment of Indonesian patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
    Rahardjo D, Soebadi DM, Sugandi S, Birowo P, Djati W, Wahyudi I.
    Int J Urol; 2006 Nov; 13(11):1405-9. PubMed ID: 17083392
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial.
    Porst H, Kim ED, Casabé AR, Mirone V, Secrest RJ, Xu L, Sundin DP, Viktrup L, LVHJ study team.
    Eur Urol; 2011 Nov; 60(5):1105-13. PubMed ID: 21871706
    [Abstract] [Full Text] [Related]

  • 14. Effects of alfuzosin 10 mg once daily on sexual function in men treated for symptomatic benign prostatic hyperplasia.
    Rosen R, Seftel A, Roehrborn CG.
    Int J Impot Res; 2007 Nov; 19(5):480-5. PubMed ID: 17717526
    [Abstract] [Full Text] [Related]

  • 15. Effect of doxazosin gastrointestinal therapeutic system 4 mg vs tamsulosin 0.2 mg on nocturia in Chinese men with lower urinary tract symptoms: a prospective, multicenter, randomized, open, parallel study.
    Zhang K, Yu W, Jin J, Ye H, Wang X, Zhang N, Yang Y, Zhong C, Wan B.
    Urology; 2011 Sep; 78(3):636-40. PubMed ID: 21696807
    [Abstract] [Full Text] [Related]

  • 16. Doxazosin gastrointestinal therapeutic system versus tamsulosin for the treatment of benign prostatic hyperplasia: a study in Chinese patients.
    Xue Z, Zhang Y, Ding Q, He Z, Wang J, Xu K.
    Int J Urol; 2007 Feb; 14(2):118-22. PubMed ID: 17302567
    [Abstract] [Full Text] [Related]

  • 17. Doxazosin for benign prostatic hyperplasia: an open-label, baseline-controlled study in Korean general practice.
    Chung BH, Hong SJ, Lee MS.
    Int J Urol; 2005 Feb; 12(2):159-65. PubMed ID: 15733110
    [Abstract] [Full Text] [Related]

  • 18. Effect of doxazosin on the symptoms of benign prostatic hyperplasia: results from three double-blind placebo-controlled studies.
    Mobley DF, Kaplan S, Ice K, Gaffney M, Dias N.
    Int J Clin Pract; 1997 Feb; 51(5):282-8. PubMed ID: 9489085
    [Abstract] [Full Text] [Related]

  • 19. Initial combined treatment with anticholinergics and α-blockers for men with lower urinary tract symptoms related to BPH and overactive bladder: a prospective, randomized, multi-center, double-blind, placebo-controlled study.
    Lee SH, Chung BH, Kim SJ, Kim JH, Kim JC, Lee JY.
    Prostate Cancer Prostatic Dis; 2011 Dec; 14(4):320-5. PubMed ID: 21788967
    [Abstract] [Full Text] [Related]

  • 20. Effect of vardenafil on blood pressure profile of patients with erectile dysfunction concomitantly treated with doxazosin gastrointestinal therapeutic system for benign prostatic hyperplasia.
    Ng CF, Wong A, Cheng CW, Chan ES, Wong HM, Hou SM.
    J Urol; 2008 Sep; 180(3):1042-6. PubMed ID: 18639296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.